Free Trial
LON:IDH

Immunodiagnostic Systems (IDH) Share Price, News & Analysis

Immunodiagnostic Systems logo

About Immunodiagnostic Systems Stock (LON:IDH)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
378
378
52-Week Range
N/A
Volume
N/A
Average Volume
14,539 shs
Market Capitalization
£108.80 million
P/E Ratio
290.77
Dividend Yield
0.50%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Immunodiagnostic Systems Holdings PLC develops, manufactures, and sells in-vitro diagnostic tests to the clinical laboratory market in the United Kingdom, the United States, Germany, France, and internationally. It develops, manufactures, and markets immunoassays and automated immunoanalyser technologies to provide diagnostic outcomes for patients. It offers IDS-iSYS multi-discipline automated systems, which is based on chemiluminescence and absorbency technology is used for immunoassay testing. The company provides its products and services for diagnosis of bone metabolism, calcium metabolism, hypertension, chronic kidney disease mineral bone disorder, growth, fertility, autoimmunity, infectious disease, sarcoidosis, and allergy. Immunodiagnostic Systems Holdings PLC was founded in 1977 and is headquartered in Boldon, the United Kingdom.

Receive IDH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Immunodiagnostic Systems and its competitors with MarketBeat's FREE daily newsletter.

IDH Stock News Headlines

EQS-News: DATAGROUP Acquires ISC Innovative Systems Consulting AG
How Trade Wars Are Creating Fresh Opportunities for Investors
Tariffs and trade tensions are back in the headlines, and while many are focused on the risks, smart investors know there’s also opportunity. New supply chain shifts, pricing power adjustments, and sector revaluations are already underway—creating openings for those who act early. That’s why we’ve just released our latest research: 📈 “From Tariffs to Returns: How to Capitalize on Trade Disputes in Your Portfolio”
IDH.L Regulatory News
See More Headlines

IDH Stock Analysis - Frequently Asked Questions

Immunodiagnostic Systems Holdings PLC (LON:IDH) issued its quarterly earnings data on Wednesday, June, 20th. The company reported $5.70 EPS for the quarter, topping the consensus estimate of $2.60 by $3.10.

Shares of IDH stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Based on aggregate information from My MarketBeat watchlists, some other companies that Immunodiagnostic Systems investors own include Dechra Pharmaceuticals (DPH), iShares Biotechnology ETF (IBB), Redrow (RDW), Netflix (NFLX), Sysco (SYY), TP ICAP Group (TCAP) and Telford Homes (TEF).

Company Calendar

Last Earnings
6/20/2018
Today
5/31/2025

Industry, Sector and Symbol

Stock Exchange
LON
Sector
Medical
Industry
Medical Appliances & Equipment
Sub-Industry
N/A
Current Symbol
LON:IDH
CIK
N/A
Fax
N/A
Employees
147,000
Year Founded
N/A

Profitability

Trailing P/E Ratio
290.77
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£34.25 million
Price / Cash Flow
4.50
Book Value
GBX 187.60 per share
Price / Book
N/A

Miscellaneous

Free Float
N/A
Market Cap
£108.80 million
Optionable
Not Optionable
Beta
N/A
The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

This page (LON:IDH) was last updated on 5/31/2025 by MarketBeat.com Staff
From Our Partners